Lilly to invest $1 billion+ in new contract manufacturing in India
Investment to expand manufacturing and global medicine supply capacity
Investment to expand manufacturing and global medicine supply capacity
Amgen India investment totals $200 million through 2025
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Total investment incurred for setting up the new R&D Rs 250 crore
The facility will accommodate over 1,500 employees
The three-day forum will feature global leaders, scientists, regulatory body representatives, industry associations, and academia among many others
Subscribe To Our Newsletter & Stay Updated